← Back to all trials
Recruiting
NCT06093477
Studying Melatonin and Recovery in Teens
Conditions: Juvenile; Scoliosis, Scoliosis Idiopathic, Scoliosis; Adolescence, Scoliosis;Congenital, Kyphosis, Spondylolisthesis, Pectus Surgery, Hip Surgery
Sex: All
Ages: 12 Years – 18 Years
Healthy volunteers: No
Phase: NA
Enrollment: 45
Sponsor: Stanford University
Location: Lucile Packard Children's Hospital Palo Alto California
Summary
The goal of this feasibility clinical trial is to learn if melatonin can help teens having major musculoskeletal surgery by promoting healthy sleep. Melatonin is available as a dietary supplement that may be effective in promoting longer, higher quality sleep. This study will assess the feasibility and acceptability of melatonin for teens undergoing major musculoskeletal surgery, as well as determine optimal measured outcomes (sleep, pain, health-related quality of life) at short- and long-term follow-up.
Eligibility Criteria
Inclusion Criteria:
Patients/youth:
* Age 12-18 years
* Participants undergoing elective major musculoskeletal surgery for eligible conditions
* California state resident
* Regular access to internet and smartphone
* Can read and understand English or Spanish
Parents/caregivers
* Biological parent or legal guardian of youth
* Can read and understand English or Spanish
Exclusion Criteria:
Patients/youth
* Prescription medication for premorbid insomnia
* Cognitive impairment or developmental delay
* Does not agree to a 1-week washout if taking over the counter supplements or other sleep aids prior to the start of the study medication
* High risk for sleep related breathing disorder
* Chronic medical condition that is severe/systemic or requires regular treatment regimen
* Psychiatric admission in prior 30 days
* Patients that underwent major surgery in the last 3 months, or those that have not fully recovered from a prior surgery
* BMI ≥ 99th percentile
* Enrollment in another therapeutic study
* Any serious underlying medical or psychiatric condition, that, in the opinion of the investigator, would contraindicate the patient's participation in the study
Source: ClinicalTrials.gov (NCT06093477). StuddyBuddy aggregates publicly available trial information.